10.24335/L18742
RoyaltyStat
Option for patent and technology sublicense to monoclonal antibodies hNM01 and 1F7, exclusively for antibody improvement platforms, and nonexclusively to make genetically engineered forms or humanized forms and to derive fully human antibodies, for therapeutic and diagnostic products.
RoyaltyStat
2001